Last reviewed · How we verify
NCT04912180: ARS
Apple Respiratory Study
trial in Acute Respiratory Infection in 108 participants. Terminated before completion.
9 June 2021
Quick facts
| Lead sponsor | Apple Inc. |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 108 |
| Start date | 6 April 2021 |
| Primary completion | 9 June 2021 |
| Estimated completion | 9 June 2021 |
| Sites | 1 location across United States |
Conditions studied
- Acute Respiratory Infection — all drugs for Acute Respiratory Infection →
- Coronavirus Infection — all drugs for Coronavirus Infection →
- Influenza — all drugs for Influenza →
Sponsor
Apple Inc. — full company profile →
Who can join
22 and older, any sex, with Acute Respiratory Infection or Coronavirus Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Apple Respiratory Study, a collaboration between researchers at Apple Inc. (the "Study Sponsor" or "Sponsor") and the Seattle Flu Study team at the University of Washington (UW) (the "UW Study Team"), is a prospective, longitudinal cohort, low risk Study to collect certain data from Apple Watch and iPhone to determine whether such data can detect physiologic and non-physiologic changes in individuals associated with respiratory illnesses due to influenza, SARS-CoV-2 and other respiratory pathogens (the "Study").
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Überwachungskapitalistische Biopolitik: Big Tech und die Regierung der Körper Surveillance-capitalist biopolitics: big tech and the governing of bodies
Maschewski F, Nosthoff A. · · 2022
Verify or expand the search:
- PubMed search for NCT04912180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Respiratory Infection
Currently open trials in the same condition.
- NCT06271655 — Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Dep · NA · active not recruiting
- NCT06379542 — Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections · Phase 3 · recruiting
- NCT05814237 — POS-ARI-ER Observational Study of Acute Respiratory Infections · recruiting
- NCT04099082 — Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans · recruiting
Other Apple Inc. trials
Trials by the same sponsor.
- NCT05872035 — Smartphone Enabled Hearing Study · NA · completed
- NCT05852951 — Cycle and Ovulation Study Expansion · completed
- NCT04699812 — Atrial Fibrillation Algorithms Clinical Validation Study · NA · completed
- NCT04247581 — ECG App Algorithms Clinical Validation Study · NA · completed
- NCT04198194 — Apple Heart & Movement Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04912180 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Apple Inc.
- Last refreshed: 14 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04912180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing